FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to cardiology and genetics, and is a method for the diagnosis of multivessel atherosclerotic lesions of the coronary arteries in patients with ischemic heart disease in abdominal obesity; according to the invention, the expression level of the microRNA-203 gene in the blood serum is determined, and at the expression level of the microRNA-203 gene equal to or greater than 101.00 conditional expression unit, multivascular atherosclerotic lesion of the coronary arteries is diagnosed.
EFFECT: invention provides a highly sensitive and specific personalized, highly accurate method for diagnosing multivessel coronary artery atherosclerotic lesions in patients with ischemic heart disease with abdominal obesity, based on the patient's epigenetic features.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITHIN A YEAR AFTER CORONARY ARTERY BYPASS GRAFTING | 2022 |
|
RU2801160C1 |
| METHOD FOR NON-INVASIVE DETERMINATION OF PRODUCTION LEVELS OF REACTIVE OXYGEN FORMS BY ADIPOCYTES OF EPICARDIAL ADIPOSE TISSUE IN PATIENTS WITH CORONARY HEART DISEASE AND CORONARY ATHEROSCLEROSIS | 2022 |
|
RU2789592C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE CARDIOVASCULAR EVENTS WITHIN A YEAR AFTER CORONARY ARTERY BYPASS SURGERY | 2020 |
|
RU2731305C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF LEFT VENTRICULAR ANEURYSM IN PATIENTS AFTER MYOCARDIAL INFARCTION, TAKING INTO ACCOUNT GENETIC FACTORS | 2022 |
|
RU2801684C1 |
| METHOD FOR RAPID DETERMINATION OF INDICATIONS FOR PERFORMING INVASIVE CORONARY ANGIOGRAPHY IN PATIENTS WITH ACUTE CORONARY SYNDROME OF MODERATE AND LOW RISK OF DEVELOPING MYOCARDIAL INFARCTION WITHOUT LIFTING SEGMENT ST ON ELECTROCARDIOGRAM | 2018 |
|
RU2685924C1 |
| METHOD FOR DETERMINING PROBABILITY OF ISCHEMIC HEART DISEASE IN YOUNG PATIENTS WITH ABDOMINAL OBESITY | 2020 |
|
RU2749293C1 |
| METHOD FOR PREDICTING ADVERSE OUTCOMES UP TO 12 MONTHS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2020 |
|
RU2747693C1 |
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS WITHIN ONE YEAR AFTER A MYOCARDIAL INFARCTION BASED ON MOLECULAR GENETIC ANALYSIS | 2021 |
|
RU2767269C1 |
| METHOD FOR PREDICTING RISK OF CORONARY ARTERY DISEASE | 2020 |
|
RU2747254C1 |
| METHOD FOR DETERMINING THE RISK OF RAPIDLY PROGRESSIVE ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE | 2022 |
|
RU2789003C1 |
